FULLER & THALER ASSET MANAGEMENT, INC.
Position in UTHR — UNITED THERAPEUTICS Corp
CIK 1082327
SAN MATEO, CA
Position in UTHR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$119,580,255
-$46,694,301 QoQ
Shares Held
220,697
-21.3% QoQ
Ownership
0.515%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#42
of 870 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FULLER & THALER ASSET MANAGEMENT, INC. holds $857,277,969 across 12 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
4,615,816 | $189,386,930 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
6,240,240 | $153,572,306 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
220,697 | $119,580,255 | |
| 4 | PBH |
Prestige Consumer Healthcare Inc.
|
2,331,821 | $110,225,178 | |
| 5 | LQDA |
Liquidia Corp
|
1,209,604 | $96,441,726 | |
| 6 | PRGO |
PERRIGO Co plc
|
7,498,227 | $77,906,578 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,632,781 | $59,106,672 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
179,149 | $30,193,772 |
All Filings in UTHR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $119,580,255 | 220,697 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $166,274,556 | 280,405 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $141,601,184 | 290,613 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $132,179,009 | 315,305 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $111,217,668 | 387,046 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $151,399,720 | 491,127 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $188,033,375 | 532,914 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $203,683,273 | 568,392 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $183,158,604 | 574,976 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $131,646,789 | 573,075 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $94,798,097 | 431,116 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $97,327,383 | 430,900 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $95,456,715 | 432,420 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $117,264,112 | 523,594 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $146,877,961 | 528,167 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $115,453,807 | 551,408 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $153,970,239 | 653,413 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $119,181,165 | 664,295 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $158,038,751 | 731,390 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $129,593,248 | 702,098 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $111,983,954 | 624,179 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $101,498,265 | 606,793 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $13,790,273 | 90,851 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||